Global Sodium Iodide 131 Therapeutic Capsule Market Growth 2024-2030

Global Sodium Iodide 131 Therapeutic Capsule Market Growth 2024-2030

The global Sodium Iodide 131 Therapeutic Capsule market size is projected to grow from US$ 139 million in 2024 to US$ 248 million in 2030; it is expected to grow at a CAGR of 10.2% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Sodium Iodide 131 Therapeutic Capsule Industry Forecast” looks at past sales and reviews total world Sodium Iodide 131 Therapeutic Capsule sales in 2023, providing a comprehensive analysis by region and market sector of projected Sodium Iodide 131 Therapeutic Capsule sales for 2024 through 2030. With Sodium Iodide 131 Therapeutic Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide 131 Therapeutic Capsule industry.

This Insight Report provides a comprehensive analysis of the global Sodium Iodide 131 Therapeutic Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide 131 Therapeutic Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide 131 Therapeutic Capsule market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide 131 Therapeutic Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide 131 Therapeutic Capsule.

The global market for Sodium Iodide-131 therapeutic capsules is relatively niche but is expected to grow steadily due to the increasing incidence of thyroid disorders, advancements in nuclear medicine technology, and expanding applications of I-131 therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide 131 Therapeutic Capsule market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
37-7400 MBq/ Capsule
7400MBq-/ Capsule

Segmentation by Application:
Thyroid Cancer Treatment
Hyperthyroidism Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ANSTO
PDRadiopharma Inc.
China Isotope & Radiation Corporation (CIRC)
International Isotopes Inc
Curium Pharma
Jubilant Pharmova
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (Rosatom)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sodium Iodide 131 Therapeutic Capsule market?

What factors are driving Sodium Iodide 131 Therapeutic Capsule market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sodium Iodide 131 Therapeutic Capsule market opportunities vary by end market size?

How does Sodium Iodide 131 Therapeutic Capsule break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.